8-KThe WireRoutine
Bylaw Amendment
Filed Oct 20, 2020 · 5y ago · Accession 0001193125-20-272900
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Tarsus Pharmaceuticals, Inc.
- Ticker
- TARS
- CIK
- 1819790
- Form type
- 8-K
- Filing date
- Oct 20, 2020
- Report date
- Oct 20, 2020
- Document
- d11649d8k.htm
- Size
- 214 KB